Lawrence Otto Klein - CBO & COO at CRISPR Therapeutics AG

Insider Transactions and Holdings

Entity Type
Individual
Role
Cbo & Coo
Issuer Symbol
CRSP on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Lawrence Otto Klein since 05 Feb 2025

Holdings reported by Lawrence Otto Klein for CRISPR Therapeutics AG

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 26,797 $1,674,890 $62.50 14 Mar 2022 Direct
Stock Option (Right to Buy) 46,200 18 Feb 2022 Direct Common Shares
Restricted Stock Units 12,500 16 Aug 2022 Direct Common Shares

Transactions reported by Lawrence Otto Klein for CRISPR Therapeutics AG

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.